The Venom Movie Has All But Solidified Sony’s Spider-Verse

Doth my eyes deceive me? Has Venom just eclipsed the $500 million mark within just four weeks of its release? This in itself is an impressive feat before we take into account that it has yet to release in Japan and China. Should those markets do what they have historically done, Venom will surpass $750 million. 

The showing thus far, coupled with its potential haul to come all but ensures two things. First, Venom with most likely get a sequel and second, Sony will move ahead with its planned Spider-Man-less Spider-verse.

For fans of the Spider-Man list of villains and movies outside of the MCU, this is a great thing. 

Marvel, as successful as they have been, need competition to come from within their own walls. Certainly, DC and Aquaman will give them some later this year. However, watching one of their own do well is different. For them it’s kind of like a bee sting. For us, it’s welcomed.

Now is the time

It’s no secret that superhero movies are here and here to stay. With Marvel planning 20 more movies beginning with phase four, DC fervently working away at their universe, Todd McFarlane relaunching Spawn, and production companies snatching up the rights to any comic book that’s done/is currently doing well, they aren’t going anywhere.

Sony needed to do something. Not since Spider-Man two has Sony had a Spider-Man movie as talked about or as well received as Venom. Even my personal biases (I didn’t really like it) haven’t hindered how well Venom has done. 

Up next for Sony is the Jared Leto led, Morbius. This is intriguing. While he is well-known within the confines of comic book pages and fans, he does not have the star power outside of both that Venom has.

Personally, I hope it does well. It’s great when obscure characters get their time to shine.

Venom is currently in theatres and will be there for at least the foreseeable future. If you’ve seen it, I’d love to know your thoughts below. If you haven’t seen it, go out, see it, and leave your thoughts below.

Cheers,

Joel